Ahmad Abdulrahman Alhulail

Dr. Ahmad Abdulrahman Alhulail

Prince Sattam Bin Abdulaziz University, Al Kharj, Ar Riyāḑ, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2020 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
AAAhmad Abdulrahman Alhulail
Ahmad Abdulrahman Alhulail
PXPingyu Xia
Pingyu Xia
XSXin Shen
Xin Shen
MNMiranda Nichols
Miranda Nichols
SVSrijyotsna Volety
Srijyotsna Volety
Uzay EmirUzay Emir
Uzay Emir

28 March 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MAMohammed S Alshuhri
Mohammed S Alshuhri
HAHaitham F. Al-Mubarak
Haitham F. Al-Mubarak
AQAbdulrahman Qaisi
Abdulrahman Qaisi
AAAhmad Abdulrahman Alhulail
Ahmad Abdulrahman Alhulail
AAAbdullah ALMansour
Abdullah ALMansour
FAFatmah Jamal Alablani
Fatmah Jamal Alablani
Background/Objectives: Glioblastoma (GBM) is an aggressive and lethal primary brain tumor with a poor prognosis, with a 5-year survival rate of approximately 5%. Despite advances in oncologic treatments, including surgery, radiotherapy, and chemotherapy, survival outcomes have remained stagnant, largely due to the failure of conventional therapies to address the tumor’s inherent heterogeneity. Radiomics, a rapidly emerging field, provides an opportunity to extract features from MRI scans, offering new insights into tumor biology and treatment response. This study evaluates the potential of delta radiomics, the study of changes in radiomic features over time in response to treatment or disease progression, exploring the potential of delta radiomics to track temporal radiation changes in tumor morphology and microstructure. Methods: A cohort of 50 female CD1 nude mice was injected intracranially with G7 glioblastoma cells and divided into irradiated (IR) and non-irradiated (non-IR) groups. MRI scans were performed at baseline (week 11) and post-radiation (weeks 12 and 14), and radiomic features, including shape, histogram, and texture parameters, were extracted and analyzed to capture radiation-induced changes. The most robust features were those identified through intra-observer reproducibility assessment, ensuring reliability in feature selection. A machine learning model was developed to classify irradiated tumors based on delta radiomic features, and statistical analyses were conducted to evaluate feature feasibility, stability, and predictive performance. Results: Our findings demonstrate that delta radiomics effectively captured significant temporal variations in tumor characteristics. Delta radiomics features exhibited distinct patterns across different time points in the IR group, enabling machine learning models to achieve a high accuracy. Conclusions: Delta radiomics offers a robust, non-invasive method for monitoring the treatment of glioblastoma (GBM) following radiation therapy. Future research should prioritize the application of MRI delta radiomics to effectively capture short-term changes resulting from intratumoral radiation effects. This advancement has the potential to significantly enhance treatment monitoring and facilitate the development of personalized therapeutic strategies.

23 April 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
AAAhmad Abdulrahman Alhulail
Ahmad Abdulrahman Alhulail
MSMahsa Servati
Mahsa Servati
NONathan Ooms
Nathan Ooms
OAOguz Akin
Oguz Akin
ADAlp Dincer
Alp Dincer
Uzay EmirUzay Emir
Uzay Emir
A reliable and practical renal-lipid quantification and imaging method is needed. Here, the feasibility of an accelerated MRSI method to map renal fat fractions (FF) at 3T and its repeatability were investigated. A 2D density-weighted concentric-ring-trajectory MRSI was used for accelerating the acquisition of 48 × 48 voxels (each of 0.25 mL spatial resolution) without respiratory navigation implementations. The data were collected over 512 complex-FID timepoints with a 1250 Hz spectral bandwidth. The MRSI sequence was designed with a metabolite-cycling technique for lipid–water separation. The in vivo repeatability performance of the sequence was assessed by conducting a test–reposition–retest study within healthy subjects. The coefficient of variation (CV) in the estimated FF from the test–retest measurements showed a high degree of repeatability of MRSI-FF (CV = 4.3 ± 2.5%). Additionally, the matching level of the spectral signature within the same anatomical region was also investigated, and their intrasubject repeatability was also high, with a small standard deviation (8.1 ± 6.4%). The MRSI acquisition duration was ~3 min only. The proposed MRSI technique can be a reliable technique to quantify and map renal metabolites within a clinically acceptable scan time at 3T that supports the future application of this technique for the non-invasive characterization of heterogeneous renal diseases and tumors.

29 November 2024 in Radiography
Verified
Journal Article
Closed access
MAMohammed S Alshuhri
Mohammed S Alshuhri
AAAhmad Abdulrahman Alhulail
Ahmad Abdulrahman Alhulail
AAA.G.M. Alqahtani
A.G.M. Alqahtani
YMY. Madkhali
Y. Madkhali
MAM. Aljuhani
M. Aljuhani
AQA.H. Qaisi
A.H. Qaisi

27 November 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
MAMohammed S Alshuhri
Mohammed S Alshuhri
AAAbdulaziz Alduhyyim
Abdulaziz Alduhyyim
HAHaitham Al-Mubarak
Haitham Al-Mubarak
AAAhmad Abdulrahman Alhulail
Ahmad Abdulrahman Alhulail
OAOthman I Alomair
Othman I Alomair
AAAbdullah ALMansour
Abdullah ALMansour
(1) Background: Colorectal cancer is the third most common type of cancer with a high mortality rate and poor prognosis. The accurate prediction of key genetic mutations, such as the KRAS status, tumor staging, and extramural venous invasion (EMVI), is crucial for guiding personalized treatment decisions and improving patients’ outcomes. MRI radiomics was assessed to predict the KRAS status and tumor staging in colorectal cancer patients across different imaging platforms to improve the personalized treatment decisions and outcomes. (2) Methods: Sixty colorectal cancer patients (35M/25F; avg. age 56.3 ± 12.9 years) were treated at an oncology unit. The MRI scans included T2-weighted (T2W) and diffusion-weighted imaging (DWI) or the apparent diffusion coefficient (ADC). The manual segmentation of colorectal cancer was conducted on the T2W and DWI/ADC images. The cohort was split into training and validation sets, and machine learning was used to build predictive models. (3) Results: The neural network (NN) model achieved 73% accuracy and an AUC of 0.71 during training for predicting the KRAS mutation status, while during testing, it achieved 62.5% accuracy and an AUC of 0.68. In the case of tumor grading, the support vector machine (SVM) model excelled with a training accuracy of 72.93% and an AUC of 0.7, and during testing, it reached an accuracy of 72% and an AUC of 0.69. (4) Conclusions: ML models using radiomics from ADC maps and T2-weighted images are effective for distinguishing KRAS genes, tumor grading, and EMVI in colorectal cancer. Standardized protocols are essential to improve MRI radiomics’ reliability in clinical practice.

26 February 2020 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
AAAhmad Abdulrahman Alhulail
Ahmad Abdulrahman Alhulail
DPDebra A. Patterson
Debra A. Patterson
PXPingyu Xia
Pingyu Xia
XZXiaopeng Zhou
Xiaopeng Zhou
CLChen Lin
Chen Lin
Uzay EmirUzay Emir
Uzay Emir